Since becoming Bright Red 6 years ago we have invested nearly £2m in various projects. We have highlighted some of these below.
We renovated three isolation rooms on Ward 33 to help improve facilities for transplant patients. Rooms now include free TV a PlayStation, and have significantly improved interior design.
We invested over £40,000 to help create a new ECP treatment centre at the NCCC. Until this time patients battling GvHD needed to travel to Rotherham.
We gave £1,500 to help fund the annual Haematology Patient Survivorship Conference. This is a highly regarded event, one which we are proud to partner.
The 100th Lee Robson Patient Care Grant was issued. These are one off financial awards given to patients in most need of assistance.
For the 3rd year in a row Bright Red provided funding to the complimentary therapy team, bringing our total investment in the service to £54,000.
Our largest educational grant finished in 2014. A £10,000 award from Bright Red gave DrArami access to a haemato-oncology and stem cell transplant fellowship at the world renowned Fred Hutchinson Cancer Research Centre in Seattle, USA.
Bright Red invested £310,000 (our largest one off grant to date) into the purchase and running of a state of the art Flow Cytometer.
The first Bright Red Outreach Nurse began her 3 year post at the Northern Centre for Cancer Care. In 2016 we agreed to extend this post for 2 years.
Our Patient Care Grants were launched in August 2012. In 2013 we would rename these grants to Lee Robson Patient Care Grants in memory of our first Ambassador.
Bright Red invested £50,000 to create a Lymphoma Biobank – a valuable resource for researchers.
The first Bright Red educational grant was issued. This enabled staff to attend the European Bone Marrow Conference in Paris.
Bright Red provided half of the funding for the George Walker Fellowship at a cost of £250,000. The recipient of this grant would go on to secure a prestigious Welcome Trust award, bringing a further £1,000,000 of research investment into the region.
MSCT 2000 was re-launched as Bright Red. The vision is to build on the £4m raised and invested by MSCT since 1988. Our aims were expanded to include improving patient care and education as well as research.